Precancer: Sequentially acquired or predetermined?

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Recognition of focal morphological intraepithelial lesions associated with the eventual development of invasive cancer has long been the sine qua non of precancer. Empirically, precancers are associated with a morphological continuum from atypia to dysplasia and invasive neoplasia. Such lesions are used as early indicators of cancers and have dramatically reduced mortality from cancers of the colon, uterine cervix, and breast. Progression has been modeled as a linear, stepwise process. Some molecular evidence supports a linear model. However, clinical studies now suggest that preexisting cofactors such as human papilloma virus (HPV) in cervical cancer determines the cell fate. Other clinical studies such as bladder, prostate, and breast suggest that many intraepithelial lesions do not progress to malignancy. The more recent experimental analyses reveal that the key molecular and genetic events even predate the emergence of visible lesions. Thus, a new nonlinear, parallel model is proposed. The parallel model suggests an origin in a putative progenitor cell that expands and invades. The clinical outcome is thus predetermined. If correct, this model suggests that "progression" to malignancy is epigenetic. Further, future assessment of biological potential will involve identification and genetic analysis of the progenitor cell populations.

Original languageEnglish (US)
Pages (from-to)171-179
Number of pages9
JournalToxicologic Pathology
Volume38
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Neoplasms
Papillomaviridae
Uterine Cervical Neoplasms
Breast
Stem Cells
Prednisolone
Viruses
Nonlinear Dynamics
Epigenomics
Colonic Neoplasms
Cells
Prostate
Molecular Biology
Linear Models
Urinary Bladder
Mortality
Population
Clinical Studies

Keywords

  • Cancer
  • Genetically engineered mice
  • Mammary gland
  • Molecular pathology
  • Mouse pathology
  • Pathobiology
  • Preneoplasia

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Cell Biology
  • Molecular Biology

Cite this

Precancer : Sequentially acquired or predetermined? / Cardiff, Robert; Borowsky, Alexander D.

In: Toxicologic Pathology, Vol. 38, No. 1, 01.2010, p. 171-179.

Research output: Contribution to journalArticle

@article{81aa69189d5d438187d44ddf36f204bf,
title = "Precancer: Sequentially acquired or predetermined?",
abstract = "Recognition of focal morphological intraepithelial lesions associated with the eventual development of invasive cancer has long been the sine qua non of precancer. Empirically, precancers are associated with a morphological continuum from atypia to dysplasia and invasive neoplasia. Such lesions are used as early indicators of cancers and have dramatically reduced mortality from cancers of the colon, uterine cervix, and breast. Progression has been modeled as a linear, stepwise process. Some molecular evidence supports a linear model. However, clinical studies now suggest that preexisting cofactors such as human papilloma virus (HPV) in cervical cancer determines the cell fate. Other clinical studies such as bladder, prostate, and breast suggest that many intraepithelial lesions do not progress to malignancy. The more recent experimental analyses reveal that the key molecular and genetic events even predate the emergence of visible lesions. Thus, a new nonlinear, parallel model is proposed. The parallel model suggests an origin in a putative progenitor cell that expands and invades. The clinical outcome is thus predetermined. If correct, this model suggests that {"}progression{"} to malignancy is epigenetic. Further, future assessment of biological potential will involve identification and genetic analysis of the progenitor cell populations.",
keywords = "Cancer, Genetically engineered mice, Mammary gland, Molecular pathology, Mouse pathology, Pathobiology, Preneoplasia",
author = "Robert Cardiff and Borowsky, {Alexander D}",
year = "2010",
month = "1",
doi = "10.1177/0192623309356447",
language = "English (US)",
volume = "38",
pages = "171--179",
journal = "Toxicologic Pathology",
issn = "0192-6233",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Precancer

T2 - Sequentially acquired or predetermined?

AU - Cardiff, Robert

AU - Borowsky, Alexander D

PY - 2010/1

Y1 - 2010/1

N2 - Recognition of focal morphological intraepithelial lesions associated with the eventual development of invasive cancer has long been the sine qua non of precancer. Empirically, precancers are associated with a morphological continuum from atypia to dysplasia and invasive neoplasia. Such lesions are used as early indicators of cancers and have dramatically reduced mortality from cancers of the colon, uterine cervix, and breast. Progression has been modeled as a linear, stepwise process. Some molecular evidence supports a linear model. However, clinical studies now suggest that preexisting cofactors such as human papilloma virus (HPV) in cervical cancer determines the cell fate. Other clinical studies such as bladder, prostate, and breast suggest that many intraepithelial lesions do not progress to malignancy. The more recent experimental analyses reveal that the key molecular and genetic events even predate the emergence of visible lesions. Thus, a new nonlinear, parallel model is proposed. The parallel model suggests an origin in a putative progenitor cell that expands and invades. The clinical outcome is thus predetermined. If correct, this model suggests that "progression" to malignancy is epigenetic. Further, future assessment of biological potential will involve identification and genetic analysis of the progenitor cell populations.

AB - Recognition of focal morphological intraepithelial lesions associated with the eventual development of invasive cancer has long been the sine qua non of precancer. Empirically, precancers are associated with a morphological continuum from atypia to dysplasia and invasive neoplasia. Such lesions are used as early indicators of cancers and have dramatically reduced mortality from cancers of the colon, uterine cervix, and breast. Progression has been modeled as a linear, stepwise process. Some molecular evidence supports a linear model. However, clinical studies now suggest that preexisting cofactors such as human papilloma virus (HPV) in cervical cancer determines the cell fate. Other clinical studies such as bladder, prostate, and breast suggest that many intraepithelial lesions do not progress to malignancy. The more recent experimental analyses reveal that the key molecular and genetic events even predate the emergence of visible lesions. Thus, a new nonlinear, parallel model is proposed. The parallel model suggests an origin in a putative progenitor cell that expands and invades. The clinical outcome is thus predetermined. If correct, this model suggests that "progression" to malignancy is epigenetic. Further, future assessment of biological potential will involve identification and genetic analysis of the progenitor cell populations.

KW - Cancer

KW - Genetically engineered mice

KW - Mammary gland

KW - Molecular pathology

KW - Mouse pathology

KW - Pathobiology

KW - Preneoplasia

UR - http://www.scopus.com/inward/record.url?scp=77952316830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952316830&partnerID=8YFLogxK

U2 - 10.1177/0192623309356447

DO - 10.1177/0192623309356447

M3 - Article

C2 - 20019354

AN - SCOPUS:77952316830

VL - 38

SP - 171

EP - 179

JO - Toxicologic Pathology

JF - Toxicologic Pathology

SN - 0192-6233

IS - 1

ER -